Fig. 3From: Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot studySurvival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the validation cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted marginally different postoperative DFS between the respective subgroupsBack to article page